Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 252,226 |
|
|||||
| News | - | ||||||
| Day High | 1.87 | Low High |
|||||
| Day Low | 1.785 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Rockwell Medical Inc | RMTI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.055 | 3.08% | 1.84 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.80 | 1.785 | 1.87 | 1.84 | 1.785 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,061 | 252,226 | $ 1.83 | $ 461,154 | - | 0.942 - 6.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:24 | 68 | $ 1.83 | USD |
Rockwell Medical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 51.85M | 28.49M | - | 72.81M | -18.68M | -0.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Rockwell Medical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RMTI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.90 | 1.961 | 1.78 | 1.86 | 131,782 | -0.06 | -3.16% |
| 1 Month | 1.99 | 2.28 | 1.78 | 1.98 | 233,246 | -0.15 | -7.54% |
| 3 Months | 2.11 | 2.48 | 1.53 | 2.00 | 268,882 | -0.27 | -12.8% |
| 6 Months | 3.74 | 6.24 | 1.53 | 3.73 | 752,784 | -1.90 | -50.8% |
| 1 Year | 1.02 | 6.24 | 0.942 | 3.36 | 484,126 | 0.82 | 80.39% |
| 3 Years | 1.08 | 6.24 | 0.20 | 1.37 | 817,552 | 0.76 | 70.37% |
| 5 Years | 3.31 | 6.88 | 0.20 | 1.69 | 784,973 | -1.47 | -44.41% |
Rockwell Medical Description
| Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. The company operates in one segment of the hemodialysis market which involves the exports, manufacture, sale, and distribution of hemodialysis products. Key revenue is generated from the United States. |
